- (Trans)dermal delivery and metabolism of cPr-PMEDAPPublication without faculty affiliation
- In Vivo Modulation of Angiogenic Gene Expression by Acyclic Nucleoside Phosphonates PMEDAP and PMEG2009 | First Faculty of Medicine
- (Trans)dermal delivery of cPr-PMEDAP, cytostatic from the class of acyclic nucleoside phosphonatesPublication without faculty affiliation
- PMEDAP and its N-6-substituted derivatives: Genotoxic effect and apoptosis in in vitro conditions2003 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Antitumour activity of N-6-substituted PMEDAP derivatives against T-cell lymphoma2001 | First Faculty of Medicine
- Experimental therapy with 9-[2-(phosphonomethoxy)ethyl]-2,6-diaminopurine (PMEDAP): Origin of resistance2007 | Second Faculty of Medicine
- Antitumour activity of a combined treatment with PMEDAP and docetaxel in the Prague inbred Sprague-Dawley/cub rat strain bearing T-cell lymphoma2001 | Third Faculty of Medicine
- Anticancer effect of PMEDAP - monitoring of apoptosis2000 | First Faculty of Medicine
- Antitumor potency of PMEDAP against T. Cell lymphomaPublication without faculty affiliation
- Antitumor potency of PMEDAP against T.Cell lymphoma2001 | Faculty of Physical Education and Sport
- Cytostatic activity of PMEDAP and induction of apoptosis in cancer cellsPublication without faculty affiliation
- Anticancer effect of combined treatment with PMEDAP and docetaxel against T-cell lymphomaPublication without faculty affiliation
- PMEDAP and its N6 - substituted Derivatives: genotoxic Effect and Apoptosis in Vitro Conditions2003 | First Faculty of Medicine
- PMEDAP and its N6 - substituted Derivatives: genotoxic Effect and Apoptosis in Vitro Conditions2003 | Faculty of Physical Education and Sport
- Transdermal and dermal delivery of cPr-PMEDAP, a potent antineoplastic drugPublication without faculty affiliation
- Experimental Therapy with 9-[2-(Phosphonomethoxy)ethyl]-2,6-diaminopurine (PMEDAP): Origin of Resistance2007 | First Faculty of Medicine
- Antitumour effect of 9-(2-(phosphonomethoxy)ethyl)-2, 6-diaminopurine (PMEDAP) in in vitro and in vivo experimentsPublication without faculty affiliation
- Enhanced topical and transdermal delivery of antineoplastic and antiviral acyclic nucleoside phosphonate cPr-PMEDAP2011 | Faculty of Pharmacy in Hradec Králové
- 9-(2-(Phoshonomethyoxy)ethyl)-2,6-diaminopurine (PMEDAP) - a Potential Drug against Hematological Malignancies - Induces Apoptosis.1999 | Faculty of Physical Education and Sport
- Expression of MRP4 and MRP5 genes is related to the PMEDAP resistance in SD lymphomaPublication without faculty affiliation
- Point mutations in human guanylate kinase account for acquired resistance to anticancer nucleotide analogue PMEG2011 | Faculty of Science
- Antitumor activity of a combined treatment with PMEDAP and Docetaxel in the Prague inbred Sprague-Dawley/Cub rat strain bearing T-cell lymphoma2001 | First Faculty of Medicine
- Antitumor activity of a combined treatment with PMEDAP and Docetaxel in the Prague inbred Sprague-Dawley/Cub rat strain bearing T-cell lymphoma2001 | Faculty of Physical Education and Sport
- Antitumor Activity of Novel Purine Acyclic Nucleotide Analogs PMEA and PMEDAP.1997 | Faculty of Physical Education and Sport
- Differential effects of acyclic nucleoside phosphonates on nitric oxide and cytokines in rat hepatocytes and macrophages2012 | First Faculty of Medicine
- Acyclic Nucleotide Analogues Suppress Growth and Induce Appoptosis in Human Leukemia Cell Lines1999 | Second Faculty of Medicine
- Differential effects of acyclic nucleoside phosphonates on nitric oxide and cytokines in rat hepatocytes and macrophages2012 | Faculty of Medicine in Pilsen, First Faculty of Medicine